ChinaDaily Briefs

Daily Brief China: Yuexiu Property, Xiabuxiabu Catering, China Mengniu Dairy Co, Shui On Land, iQIYI Inc, Tencent, Legend Biotech Corp, iMotion Automotive Technology and more

In today’s briefing:

  • Big Yuexiu Property (123 HK) Rights Issue – 3 Capital Actions from Here to Mid-June
  • Yuexiu Property (123 HK): US$1.1bn Dilutive and Unnecessary Rights Issue
  • China Catering Sector: Long Xiabuxiabu / Short Jiumaojiu
  • HSCEI Stocks to Buy at a Material Discount – Targeted Buying Levels in 2319 HK / 2020 HK / 9888 HK
  • Morning Views Asia: Renewable Energy Group, Sands China, Shui On Land, Vedanta Resources
  • [iQIYI, Lnc. (IQ US) Target Price Change]: Reiterate SELL for Increasing Competition
  • Tencent/Netease: Zeroed in April
  • Legend Biotech (LEGN US): Shares Popped on Promising Clinical Data; Further Upside Potential Remains
  • IMotion Automotive Technology Pre-IPO – The Negatives – But Profitability Still a Black Box

Big Yuexiu Property (123 HK) Rights Issue – 3 Capital Actions from Here to Mid-June

By Travis Lundy

  • After being halted this morning before the start of trade, post-close, Yuexiu Property (123 HK) announced a fully-underwritten Rights Offering. 
  • The Rights Offering intends to raise HK$8.36bn issuing 30 Rights for every 100 Shares held, at a subscription price of HK$9.00, a 23.3% discount to TERP. 
  • This will take a moderately-levered property/services/leaseco and add more capital to it. Not terribly bullish. Looks opportunistic. And one has to look through 3 capital actions to see dividends ahead.

Yuexiu Property (123 HK): US$1.1bn Dilutive and Unnecessary Rights Issue

By Arun George

  • Yuexiu Property (123 HK) will raise US$1.1bn through a rights offering – 30 rights shares for every 100 existing shares. The subscription price is HK$9.00, a 23.3% discount to TERP.
  • As Yuexiu is in no danger of breaching the three red lines, the rights issue is an opportunistic play on capitalising on the strong share price run.
  • Rights shares will be entitled to the final and special dividend announced on 15 March. Shares go ex-rights on 2 May and the rights start trading on 15 May.

China Catering Sector: Long Xiabuxiabu / Short Jiumaojiu

By Eric Chen

  • We believe the recovery of China consumption is “not yet solid”, but not faltering.
  • China catering sector’s recovery stays on track, although Q2 has historically been a low season.
  • Long Xiabuxiabu and short Jiumaojiu to play the sector’s recovery while hedging against potential macro weakness.

HSCEI Stocks to Buy at a Material Discount – Targeted Buying Levels in 2319 HK / 2020 HK / 9888 HK

By David Coloretti, CMT

  • At TMA we deliver high probability outcomes by focusing on our 3 pillars of technical analysis. 1) Response to key levels. 2) Price action. 3) Momentum confirmation.
  • China Mengniu Dairy Co Ltd (2319 HK), ANTA Sports Products Ltd (2020 HK) and Baidu Inc (9888 HK) are all trading at significant discounts to 2023 highs and LT highs.
  • Today we highlight targeted support levels / buying opportunities in the coming 1-2 days in 2319 HK, 1-3 weeks in 2020 HK and 1-3 months in 9888 HK). 

Morning Views Asia: Renewable Energy Group, Sands China, Shui On Land, Vedanta Resources

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


[iQIYI, Lnc. (IQ US) Target Price Change]: Reiterate SELL for Increasing Competition

By Shawn Yang

  • We forecast iQIYI 1Q23 top line/bottom line to miss cons. by (3.6%)/(6.3%), largely due to the rebound of content costs to cope with competition pressure. 
  • We raise our full year ads revenue estimate slightly to reflect the better-than-expected macro recovery. Our top and bottom lines in 2023 are (3.3%)/(7.0%) vs cons, due to long-term competition. 
  • Maintain SELL but slightly raise TP to US$ 5.60, implying 18.4X PE in 2023.

Tencent/Netease: Zeroed in April

By Ke Yan, CFA, FRM

  • China just announced game approval for April batch. The number of games approved is in-line with the pace of approval in recent month.
  • Pace of China game approval stays flattish, at a much slower pace than pre-tightening.
  • Both Tencent and Netease received approval for none. Tencent is behind its peers since the approval resumed.

Legend Biotech (LEGN US): Shares Popped on Promising Clinical Data; Further Upside Potential Remains

By Tina Banerjee

  • Legend Biotech Corp (LEGN US) shares broke into a new high after a leaked abstract showed Carvykti cuts risk of progression or death by 74% in earlier multiple myeloma therapy.
  • Success of Carvykti in earlier lines of MM therapy will lead to rapid intake of the drug and increase the drug’s peak sales opportunity to $5B.
  • During 2022, Carvykti generated ~$134M in net trade sales. With label and geography expansion of Carvykti, Legend Biotech shares still have further upside potential.  

IMotion Automotive Technology Pre-IPO – The Negatives – But Profitability Still a Black Box

By Ethan Aw

  • IMotion Automotive Technology (1812706D CH) is looking to raise about US$300m in its upcoming HK IPO. 
  • The company possesses advanced full-stack R&D capabilities including self-developed algorithms and hardware-software co-design capabilities. It provides two AD domain controller product lines, and the self-designed iDC series. 
  • In this note, we talk about the not-so-positive aspects of the deal.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars